# Zosano Pharma Corp

Zosano Pharma Corp is a company headquartered in Fremont, CA, United States.

## Company overview

- **Legal name:** Zosano Pharma Corp
- **Former names in filing history:** ZP Holdings Inc (2013-09-20 to 2014-05-13)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Fremont, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001587221

## About

Zosano Pharma Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001587221, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-03-17, it reported annual revenue of USD 785,000; net income of USD -29,925,000; total assets of USD 48,390,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $785,000 (USD 785,000)
- **Net income:** -$29.9M (USD -29,925,000)
- **Total assets:** $48.4M (USD 48,390,000)
- **Cash and equivalents:** $11.0M (USD 11,043,000)
- **Operating cash flow:** -$27.6M (USD -27,590,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $224,000 (USD 224,000)
- **Net income:** -$33.4M (USD -33,369,000)
- **Total assets:** $72.0M (USD 72,011,000)
- **Cash and equivalents:** $35.3M (USD 35,263,000)
- **Operating cash flow:** -$31.7M (USD -31,718,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$37.6M (USD -37,589,000)
- **Total assets:** $37.7M (USD 37,670,000)
- **Cash and equivalents:** $6.3M (USD 6,316,000)
- **Operating cash flow:** -$34.8M (USD -34,817,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$35.4M (USD -35,358,000)
- **Total assets:** $35.8M (USD 35,780,000)
- **Cash and equivalents:** $9.1M (USD 9,140,000)

## Recent SEC filings

- Form 8-K — filed 2022-06-03 — period 2022-06-02 — 8-K
- Form 8-K — filed 2022-06-02 — period 2022-05-26 — 8-K
- Form SC 13G — filed 2022-05-18 — SCHEDULE 13G
- Form 8-K — filed 2022-05-18 — period 2022-05-16 — 8-K
- Form 10-Q — filed 2022-05-13 — period 2022-03-31 — 10-Q
- Form 8-K — filed 2022-05-13 — period 2022-05-10 — 8-K
- Form 8-K — filed 2022-05-05 — period 2022-05-03 — 8-K
- Form 8-K — filed 2022-04-29 — period 2022-04-29 — 8-K
- Form 10-K/A — filed 2022-04-29 — period 2021-12-31 — 10-K/A
- Form 8-K — filed 2022-04-11 — period 2022-04-08 — 8-K
- Form 10-K — filed 2022-03-17 — period 2021-12-31 — 10-K
- Form 8-K — filed 2022-03-17 — period 2022-03-17 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/zosano-pharma-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology